Quantitative Systematic Strategies LLC Aldeyra Therapeutics, Inc. Transaction History

Quantitative Systematic Strategies LLC

  • $0
  • Q3 2022

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 06, 2021
SELL
$6.53 - $14.42 $42,921 - $94,782
-6,573 Reduced 25.8%
18,902 $225,000
Q4 2020

Feb 09, 2021
SELL
$6.31 - $8.13 $108,405 - $139,673
-17,180 Reduced 40.28%
25,475 $175,000
Q3 2020

Nov 09, 2020
BUY
$4.0 - $7.53 $22,768 - $42,860
5,692 Added 15.4%
42,655 $316,000
Q2 2020

Aug 04, 2020
BUY
$1.97 - $5.05 $72,817 - $186,663
36,963 New
36,963 $154,000

Others Institutions Holding ALDX

# of Institutions
119
Shares Held
36.7M
Call Options Held
196K
Put Options Held
142K
View Full List

About Aldeyra Therapeutics, Inc.

ALDX Quotes by TradingView
  • Ticker ALDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,323,100
  • Market Cap $344M
  • Description
  • Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It al...
More about ALDX
Track This Portfolio

Track Quantitative Systematic Strategies LLC Portfolio

Follow Quantitative Systematic Strategies LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantitative Systematic Strategies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quantitative Systematic Strategies LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email